Literature DB >> 2125070

In situ hybridization of immunoglobulin light chain mRNA in paraffin sections using biotinylated or hapten-labelled oligonucleotide probes.

J H Pringle1, A K Ruprai, L Primrose, J Keyte, L Potter, P Close, I Lauder.   

Abstract

An in situ hybridization technique has been developed for the detection of immunoglobulin light chain mRNA in routine pathology specimens. The method detects kappa or lambda constant region sequences using a cocktail of synthetic oligonucleotide probes labelled with biotin or fluorescein 5-isothiocyanate (FITC) reporter molecules. The probes were labelled at flanking sites chemically by primary amine directed acylation and by 'homopolymer tailing' with terminal deoxynucleotidyl transferase using non-radioactive nucleotide analogues. The mRNA was unmasked in the formalin-fixed tissue sections by digestion with varying concentrations of proteinase K, and the hybrids were demonstrated using alkaline phosphatase with either a streptavidin/biotin based four-stage system or an anti-FITC antibody based detection system. Alkaline phosphatase was visualized using a Fast Red naphthol-capture method and the sections were counterstained with haematoxylin. The results confirm that the method is specific for kappa or lambda mRNA and show that specific mRNAs can be detected in routine formalin-fixed sections using non-radioactive techniques with retention of good morphology. The method reliably detects light chain mRNA in cells expressing secretory immunoglobulin. The protocol can also be applied to tissue rich in endogenous biotin by using hapten-labelled probes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125070     DOI: 10.1002/path.1711620305

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

Review 1.  In situ hybridisation in perspective.

Authors:  A Warford; I Lauder
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

2.  Comparison of in situ hybridisation and polymerase chain reaction in the diagnosis of B cell lymphoma.

Authors:  A M McNicol; M A Farquharson; F D Lee; A K Foulis
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

3.  Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA.

Authors:  S J Harper; A C Allen; J H Pringle; J Feehally
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

4.  A comparative study of digoxigenin, 2,4-dinitrophenyl, and alkaline phosphatase as deoxyoligonucleotide labels in non-radioisotopic in situ hybridisation.

Authors:  S J Harper; E Bailey; C M McKeen; A S Stewart; J H Pringle; J Feehally; T Brown
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

5.  Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation.

Authors:  E Bailey; M J Bottomley; S Westwell; J H Pringle; P N Furness; J Feehally; P E Brenchley; S J Harper
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

6.  Simultaneous in situ hybridisation of native mRNA and immunoglobulin detection by conventional immunofluorescence in paraffin wax embedded sections.

Authors:  S J Harper; J H Pringle; A Gillies; A C Allen; L Layward; J Feehally; I Lauder
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

7.  In situ detection of human Ig light-chain mRNA on formalin-fixed and paraffin-embedded tissue sections using digoxigenin-labelled RNA probes.

Authors:  L Pan; L C Happerfield; L G Bobrow; P G Isaacson
Journal:  Histochem J       Date:  1993-01

8.  Demonstration of mRNA using digoxigenin labelled oligonucleotide probes for in situ hybridisation in formamide free conditions.

Authors:  G A Thomas; H G Davies; E D Williams
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

9.  Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA.

Authors:  S J Harper; A C Allen; M C Béné; J H Pringle; G Faure; I Lauder; J Feehally
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.